Bausch Health
BHC
#3481
Rank
S$4.25 B
Marketcap
$11.51
Share price
-2.04%
Change (1 day)
25.62%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : S$28.84 Billion

According to Bausch Health 's latest financial reports the company's total debt is S$28.84 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31S$29.56 B6.21%
2022-12-31S$27.83 B-9.1%
2021-12-31S$30.62 B-3.24%
2020-12-31S$31.65 B-9.34%
2019-12-31S$34.91 B5.14%
2018-12-31S$33.20 B-2.43%
2017-12-31S$34.03 B-21.22%
2016-12-31S$43.19 B-1.82%
2015-12-31S$43.99 B118.56%
2014-12-31S$20.13 B-8.58%
2013-12-31S$22.01 B63.3%
2012-12-31S$13.48 B56.55%
2011-12-31S$8.61 B81.15%
2010-12-31S$4.75 B763.39%
2009-12-31S$0.55 B504.55%
2008-12-31S$91.09 M
2006-12-31S$0.62 B-13.46%
2005-12-31S$0.72 B-6.91%
2004-12-31S$0.78 B-43.4%
2003-12-31S$1.38 B6.46%
2002-12-31S$1.29 B1417.51%
2001-12-31S$85.45 M-93.33%
2000-12-31S$1.28 B459.23%
1999-12-31S$0.22 B9.28%
1998-12-31S$0.20 B2436.03%
1997-12-31S$8.26 M-15.67%
1996-12-31S$9.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.36 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA